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Abstract
Bcor (BCL6 corepressor) is a widely expressed gene that is mutated in patients with X-linked Oculofaciocardiodental (OFCD)
syndrome. BCOR regulates gene expression in association with a complex of proteins capable of epigenetic modification of
chromatin. These include Polycomb group (PcG) proteins, Skp-Cullin-F-box (SCF) ubiquitin ligase components and a Jumonji
C (Jmjc) domain containing histone demethylase. To model OFCD in mice and dissect the role of Bcor in development we
have characterized two loss of function Bcor alleles. We find that Bcor loss of function results in a strong parent-of-origin
effect, most likely indicating a requirement for Bcor in extraembryonic development. Using Bcor loss of function embryonic
stem (ES) cells and in vitro differentiation assays, we demonstrate that Bcor plays a role in the regulation of gene expression
very early in the differentiation of ES cells into ectoderm, mesoderm and downstream hematopoietic lineages. Normal
expression of affected genes (Oct3/4, Nanog, Fgf5, Bmp4, Brachyury and Flk1) is restored upon re-expression of Bcor.
Consistent with these ES cell results, chimeric animals generated with the same loss of function Bcor alleles show a low
contribution to B and T cells and erythrocytes and have kinked and shortened tails, consistent with reduced Brachyury
expression. Together these results suggest that Bcor plays a role in differentiation of multiple tissue lineages during early
embryonic development.
Citation: Wamstad JA, Corcoran CM, Keating AM, Bardwell VJ (2008) Role of the Transcriptional Corepressor Bcor in Embryonic Stem Cell Differentiation and Early
Embryonic Development. PLoS ONE 3(7): e2814. doi:10.1371/journal.pone.0002814
Editor: Joseph Najbauer, City of Hope Medical Center, United States of America
Received August 23, 2007; Accepted July 2, 2008; Published July 30, 2008
Copyright:  2008 Wamstad et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding for this work was provided by NCI (R01 CA071540), NIH (T32DE07288) and the University of Minnesota Cancer Center. The funding agencies
had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bardw001@umn.edu
Introduction
Mutations causing gene fusions, loss of function or misregulation
of transcriptional corepressor proteins have been implicated both in
genetically inherited diseases and cancer [1,2]. BCOR (BCL6
corepressor) is a transcriptional corepressor that was originally
identified by its ability to interact with the site specific transcrip-
tional repressor BCL6 [3]. BCOR is found in an 800 kDa complex
in which at least two proteins have chromatin modifying activity: the
PcG transcriptional repressor protein, RNF2, is a histone H2A E3
ubiquitin ligase and FBXL10 (JHDM1B, KDM2B) is a Jmjc histone
demethylase in addition to its presumed ubiquitin E3 ligase activity
[4,5]. BCL6 plays critical roles in specific immunological processes
involving B and T cells, including germinal center formation and the
generation and maintenance of memory T cells [6–10]. In addition,
testicular germ cell apoptosis and defects in erythropoiesis have been
reported in BCL6-deficient mice [11,12]. Deregulated expression of
BCL6, due to chromosomal translocations or point mutations, is
associated with the formation of approximately one sixth of non-
Hodgkin’s lymphomas [13,14]. In cell lines derived from such
patients, BCOR is detected at a number of BCL6 target genes
suggesting that BCOR is likely to play a role in mediating BCL6
driven lymphomagenesis. Since its original discovery, BCOR has
been shown to directly interact with the transcriptional regulator
AF9 (MLLT3), and to be in a complex with ENL (MLLT1). AF9
and ENL are known MLL (trithorax) fusion partners in acute
leukemias [15]. AF9 itself is a regulator of Hox gene expression and
skeletal development [16,17].
In addition, BCOR has been shown to play multiple roles in the
complex process of human development. Females who are
heterozygous for X-linked Bcor mutations have the rare Oculofa-
ciocardiodental (OFCD) syndrome, the primary subtype of
OMIM #300166 microphthalmia, syndromic 2 (MCOPS2)
[18]. Congenital disorders in patients suffering from OFCD
include cataracts, microphthalmia, and cardiac, dental and digital
anomalies [18,19]. In the hematopoietic lineage of OFCD
patients, Bcor clearly is critical as 90–100% of surviving white
blood cells show inactivation of the X- chromosome carrying the
mutant allele of Bcor [18]. Presumably, the selective disadvantage,
caused by an active X-chromosome harboring a Bcor mutation, is
less severe in some tissues leading to variable phenotypic effects in
a mosaic fashion. Male OFCD patients do not exist and are
presumed to die in early development. Almost all Bcor mutations in
OFCD patients result in premature stop codons that are thought
to cause nonsense-mediated decay of the mRNA [18]. The second
form of MCOPS2, Lenz microphthalmia, results from a single
missense mutation (p. P85L) in the fourth coding exon of Bcor and
is inherited in an X-linked recessive pattern [18]. Patients with
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2814Lenz microphthalmia suffer from microphthalmia/anophthalmia,
mental retardation, and skeletal and other anomalies [18,20].
The severity and breadth of these two MCOPS2 syndromes
illustrate the important roles Bcor plays during development.
Currently two animal models have successfully recapitulated
developmental abnormalities similar to those found in patients
with OFCD and Lenz microphthalmia. RNAi knock down of Bcor
in zebrafish (Danio rerio) results in colobomatous eye defects and
perturbations in somite, skeletal and neural tube development
[18]. Colobomas, microphthalmia and cardiac abnormalities were
also seen in morpholino knock down of Bcor in frogs (Xenopus
tropicalis). Additionally, laterality defects were observed in Bcor
morpholino injected frogs, similar to those present in a subset of
OFCD patients [21].
The expression of Bcor during mouse development correlates
well with tissues and organs in adversely affected patients with
OFCD or Lenz microphthalmia [22]. Three separate promoters
differentially control the expression of Bcor through embryonic
development and into adulthood. Section in situ analysis shows that
Bcor mRNA is expressed strongly in extraembryonic tissues during
gastrulation and embryonic turning, suggesting a significant role in
placental formation. Bcor expression is upregulated in the embryo
proper at embryonic day 9 in mice starting in the tail, limb buds
and branchial arches. During the later fetal stages of mouse
development, Bcor is expressed in multiple tissues including strong
expression in lens and retina of the eye and the neural tube [22].
The abnormalities present in Bcor knockdown fish and frogs,
combined with the severe clinical presentation of MCOPS2
syndromes in humans, clearly illustrate the importance of Bcor in
development. The developmental requirement for Bcor, together
with its potential role in BCL6-related lymphomagenesis,
underscores the importance of generating and analyzing mutant
alleles of Bcor. To this end, we have analyzed the effect of two
independent Bcor loss of function alleles on early development in
mice and in ES cell differentiation. We found that Bcor exhibits a
parent-of-origin effect, in that only paternal transmission results in
viable offspring. Since the paternal X chromosome is exclusively
inactivated in the extraembryonic tissue, this strongly suggests Bcor
is required for extraembryonic development. In addition, loss of
Bcor results in compromised development during in vitro differen-
tiation of embryonic stem cells.
Results
Generation and analysis of a conditional Bcor allele
To investigate the role of the X-linked Bcor gene in
development, we generated a conditional Bcor allele, Bcor
Fl,i n
which exon 3 is flanked by loxP sites to allow its removal via
expression of Cre recombinase (Figure 1A and targeting
verification Figure 1B). We hypothesized that excision of exon 3
(Bcor
D3) would result in a frame shift and a premature stop codon
that should cause severe carboxy-terminal deletion of the BCOR
protein and/or elimination of the mRNA by nonsense-mediated
decay (Figure 1C). Based on human OFCD patients we expected
that heterozygous female mice carrying this deletion in all tissues
would recapitulate the phenotype of human OFCD patients and
that hemizygous male mice would not be viable. Unexpectedly,
breeding Bcor
Fl/+ mice to ß-actin-Cre mice generated apparently
normal female (Bcor
D3/+) and male (Bcor
D3/Y) mice. Western blot
analysis of BCOR protein from the eyes of these mice and wild
type controls revealed that an alternative start codon, 39 to the
engineered frame shift, was used for translation, generating BCOR
protein with a predicted 71 amino acid amino-terminal deletion
(Figure 1C). Thus, although this amino-terminal region is
conserved, with 69% identity to the Xenopus protein and 90%
identity to that of human, it is not essential.





Fl mutation did not provide the expected null
allele, during the initial targeting of the Bcor locus we fortuitously
created a loss of function Bcor allele (Bcor
Neo) that provided insights
into Bcor function both in mice and in ES cell differentiation. We
included a Neomycin (Neo) selection cassette in the Bcor targeting
vector. Often the Neo cassette is excised during mRNA splicing to
generate a normal transcript. However, in some cases a proportion
of mRNAs are spliced into and then out of Neo, and the insertion of
Neo sequences can result in a hypomorphic or null allele [23,24].
Phenotypic effects of such aberrant splicing in chimeric animals
would bemostreadilyobserved for X-linked genes likeBcorsinceXY
ES cells are routinely used for gene targeting. Upon generation of
chimeric mice with our Bcor
Neo/Y ES cells (Figure 2A) we observed
two prominent phenotypes suggesting that the Neo cassette was
indeed interfering with Bcor expression and function (Figure 2B).
First, 3 out of 10 Bcor
Neo chimeras had kinked and sometimes
shortened tails,suggesting a possibleneural tube defect[25].Second,
10 out of 10 chimeras exhibited a consistent bias in coat color
contributionofthe129(Agouti)EScellstothesidesofthebodiesand
legs of the mice. Since Agouti locus expressing cells in the skin are
derived from the ectodermal lineage, this indicates a selective bias
against Bcor
Neo/Y cells to contribute to certain ectodermal lineages.
The sametail and coat color phenotype wasalsoobserved in3 out of
3 chimeric mice that we generated from the Bay Genomics ES cell
line, XE541 (Bcor
Gt) (Figure 2B). The XE541 ES cell line harbors an
insertional gene trap mutation (ß-Geo) in the 6
th intron of mouse
Bcor, which is predicted to result in an N-terminal BCOR-ß-Geo
fusion protein (Figure 2A).
Molecular analysis of Bcor
Neo and Bcor
Gt alleles
To establish the molecular nature of the expression defects of
the Bcor
Neo and Bcor
Gt alleles in ES cells, we examined Bcor mRNA
splicing patterns by RT-PCR and proteins levels by western blot
analysis. The Bcor
Neo allele ES cells had a mixture of transcripts
spliced to exclude Neo (Figure 2A, left upper splicing pattern and
Figure S1A), which encode intact BCOR, together with transcripts
spliced to incorporate the Neo cassette (Figure 2A, left lower
splicing pattern and Figure S1A). Sequencing of RT-PCR
products demonstrated that the two regions of the Phosphoglyc-
erate Kinase-Neomycin (Pgk-Neo) cassette were recognized as
exons by the splicing machinery (Figure S1B). The first exon was
86 nucleotides from the Pgk promoter and the second utilized a
splice acceptor site within the 59 UTR of the Neo gene cassette and
a donor site within the 39UTR. This latter exon was identical to
that used by other previously reported targeted genes [24]. The
result of this splicing is the introduction of a premature in frame
stop codon derived from the Pgk promoter sequence. Splicing into
Neo predominates, as full length BCOR protein levels are not
detectable by western blot analysis in the Bcor
Neo allele ES cells as
compared to the parental ES cell line CJ7 (Figure 2C). We
conclude that the Bcor
Neo allele is a severe loss of function allele but
because we did detect some correctly spliced transcript it may not
be a null allele.
The transcripts from the Bcor
Gt allele are a mixture of those that
splice over the gene trap cassette (Figure 2A, right upper splicing
panel and Figure S1B) which encode intact BCOR and those that
splice into the gene trap ß-Geo cassette, truncating the gene
(Figure 2A, right, lower splicing pattern and Figure S1B). By
western blot analysis the large BCOR-ß-Geo fusion protein and
Bcor in Early Development
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a faint band corresponding to full length BCOR is present this
may represent a co-migrating BCOR-ß-Geo degradation product.
The BCOR-ß-Geo fusion protein lacks the region required for
interaction with the PcG proteins [4] and therefore is predicted to
lack transcriptional repression activity. Although the fusion protein
appears to be unstable, the total amount of protein is significantly
higher than the level of intact BCOR found in the parental ES cell
Figure 1. Generating Bcor
D3/+ and Bcor
D3/Y mice. (A) Diagram of targeting construct and recombination strategy. The Bcor
+ allele was targeted
by homologous recombination to generate Bcor
Neo embryonic stem cells. This allele contains loxP sites flanking the third exon, and a Neo resistance
cassette flanked by frt sites, internal to the loxP sites immediately downstream of exon 3. Expression of Flp and/or Cre site specific recombinases in
vivo or in vitro can be used to excise the intervening sequence between their respective recognition sites, frt and loxP, generating Bcor
Fl and Bcor
D3
alleles. PGK-Neo (phosphoglycerate kinase promoter–driven neomycin resistance gene cassette) (B) Southern blot and PCR analyses of targeted and
wild type ES cell clones. Genomic DNA from individual ES cell clones was digested with the restriction enzymes, BamH1 (left arm) and BglII (right arm).
The 59 external probe (Left Arm) hybridizes to 10.7-kb (Bcor
+/Y) and 9.5-kb (Bcor
Neo/Y) BamH1 fragments. Given the weak left arm signal, confirmatory
PCR was performed on genomic DNA from wild type and targeted ES cells using a forward primer 59 to the left arm and a reverse primer in the
neomycin coding sequence. The 39 external probe (Right Arm) hybridizes to 12.3-kb (Bcor
+/Y) and 10.5-kb (Bcor
Neo/Y) BglII fragments. (C) The Bcor
D3
allele encodes an N-terminally truncated version of BCOR. The anticipated and actual translation open reading frames for the Bcor
D3 allele are
diagrammed (top). Western blot analysis on the eyes of Bcor
+/+, Bcor
D3/+ and Bcor
D3/Y mice (bottom) reveals the presence of an N-terminally
truncated version of BCOR (red arrows) in both the Bcor
D3/+ and Bcor
D3/Y lanes, migrating at a slightly lower molecular weight in comparison to wild
type BCOR (black arrows).
doi:10.1371/journal.pone.0002814.g001
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quantitative-RT-PCR, that the Bcor-ß-Geo fusion transcript level is
10-fold higher than the level of intact Bcor transcript found in the
parental ES cell line. This suggests that intact BCOR negatively
autoregulates its own transcription while the BCOR-ß-Geo fusion
is unable to function in this capacity. In summary, both the Bcor
Neo
and Bcor
Gt alleles represent severe loss of function mutations and
result in kinked and shortened tails and a coat color bias in
chimeric animals.
Parent-of-origin effect of Bcor
Neo allele
To further characterize the effect of these two loss of function
mutations in mice we bred the male chimeras to wild type females
to obtain germline transmission of the alleles. This was only
successful with the Bcor
Neo allele and we were able to produce
Bcor
Neo/+ females. (Because Bcor is X-linked, Bcor
Neo/Y males cannot
be generated from male chimeras.) Germline transmission of the
Bcor
Gt allele did not occur and there are at least two possible
explanations for this. First, the Bcor
Gt allele may not be compatible
Figure 2. Transmission of the Bcor
Neo and Bcor
Gt alleles in mice. (A) Diagram of Bcor
Neo and Bcor
Gt allele transmission. Location of each
genomic alteration is shown, respective to the Bcor locus (top). The splicing pattern of each allele is indicated with the more predominant splicing
pattern drawn below each allele in a darker line. See Supplementary Figure 1 for detailed analysis. The mating schemes for Bcor
Neo and Bcor
Gt mouse
lines are depicted below the genomic alterations. (B) Bcor
Neo and Bcor
Gt chimeric mice and Bcor
Neo/+ mice display similar phenotypes. Coat color




Neo/+ offspring of Bcor




Fl/Y (rescued line), E14 (Bcor
Gt/Y parent) and Bcor
Gt/Y ES cell lines. The top panel was probed with an anti-BCOR
antibody and anti-ACTIN antibody was used as a loading control on the bottom panel. BCOR protein is undetectable in Bcor
Neo/Y ES cells. Bcor
Fl/Y
rescued ES cells show wild type levels of BCOR. Bcor
Gt/Y ES cells show a large BCOR-ß-Geo fusion protein with multiple breakdown products. (D)
Parent-of-origin effect of Bcor
Neo allele. Matings between Bcor
Neo/+ females (offspring of Bcor
Neo male chimeras) and wild type males do not produce
any offspring carrying the Bcor
Neo allele. In mice, the paternal X chromosome is selectively inactivated in extraembryonic tissue whereas in the
embryo proper X inactivation occurs randomly (grey text indicates paternally imprinted X inactivation). The female lethality observed likely results
from paternally imprinted X-inactivation of the wild type Bcor allele in extraembryonic tissue.
doi:10.1371/journal.pone.0002814.g002
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Gt
chimeric mice were obtained and bred, it is possible that upon
generation of more chimeras germline transmission would occur.
We bred the female Bcor
Neo/+ mice extensively but, in contrast to
the chimeric males, they never produced any Bcor
Neo/+ offspring
(Figure 2A and D). (Bcor
Neo/Y males, based on the lack of male
OFCD patients, are predicted to die during embryonic develop-
ment.) However, we were able to breed the female Bcor
Neo/+ mice
to FLPe recombinase expressing mice to remove Neo, and got
viable Bcor
Fl/+ and Bcor
Fl/Y progeny (Figure 2A). In mice, X
chromosome inactivation differs between the embryo and the
extraembryonic tissue. The embryo undergoes random X-
inactivation, in contrast to the extraembryonic tissue where the
paternally-derived X chromosome is inactivated [26]. The female
lethality observed, arising when the mutant X-linked allele comes
from the mother, likely results from paternally-imprinted X-
inactivation of the wild type Bcor allele in extra-embryonic tissue of
the female offspring (Figure 2D and see discussion). Thus, our
results are consistent with a requirement for Bcor in extraembry-
onic tissue where Bcor is normally highly expressed [22]. The
practical consequence of this parent-of-origin effect was that we
could not generate extensive numbers of Bcor
Neo/+ mice and thus
phenotypic analysis was limited to the Bcor
Neo and Bcor
Gt allele-
containing chimeras and the remaining six aging female Bcor
Neo/+
mice that were generated from the two germline-transmitting male
chimeras we obtained.
Effect of Bcor
Neo allele on eye development
In OFCD congenital cataracts have been described in all
patients. We examined the eyes of the remaining Bcor
Neo/+ mice
when they ranged in age from 7 to 22 months. Using a slit lamp,
the mice were examined for lens opacification, which is indicative
of catararacts. Eight out of twelve eyes (67%) in the six Bcor
Neo/+
mice displayed lens opacification. Although we do not know the
age of onset, two of Bcor
Neo/+ mice that were 7 months of age had
bilateral lens opacification. We did not have aged matched
C57Bl/6:129 mixed background control animals. However, the
frequency of cataracts in the Bcor
Neo/+ mice was substantially
higher than that reported for either C57Bl/6 or 129 inbred stains
(C57Bl/6 is 25% at 14 months [27] and 129 0% at 13–17 months,
as detected by slit lamp analysis [28]). Over seventy percent of
OFCD patients have microphthalmia. By visual inspection we
only observed one Bcor
Neo allele-containing chimera with obvious
microphthalmia. However, we did not perform postmortem globe
measurements so we cannot rule out the possibility that additional
mice had more subtle microphthalmia.
Analysis of Bcor
Neo/Y and Bcor
Gt/Y cell contribution to
hematopoietic development
In OFCD patients 90–100% of surviving white blood cells show
inactivation of the X chromosome carrying the mutant allele of
Bcor, indicating that cells expressing the mutant allele of Bcor are at
a selective disadvantage [18]. Because the majority of white blood
cells are neutrophils and T cells (and to a lesser extent B cells) this
strongly suggests that Bcor plays an important role in the
development of these hematopoietic lineages.
We hypothesized that the loss of function mutations in the
Bcor
Neo/Y and Bcor
Gt/Y ES cell would result in reduced or blocked
contribution to hematopoietic lineages in our chimeric mice. The
contributions of Bcor
Neo/Y and Bcor
Gt/Y 129 strain ES cells to splenic
B and T cells of 129/B6 chimeric animals were analyzed by
fluorescence activated cell sorting (FACS). We used the 129 strain-
specific B and T cell surface antigen Ly9.1 [29,30], the commonly
used T-cell markers CD4 and CD8, and the B-cell marker CD19.
We found that Ly9.1 positive cells can contribute to CD4, CD8
and C19 positive hematopoietic populations in Bcor
Neo/Y and
Bcor
Gt/Y chimeric mice (Figure 3A and B). The 129 contribution to
each hematopoietic cell type tested was reduced relative to two
control chimeras in three Bcor
Neo/Y and three Bcor
Gt/Y chimeric
mice. CD4+, CD8+ and CD19+ were reduced compared to
control chimeras on average by 87%, 86% and 85%, respectively.
Thus, the Bcor
Neo/Y and Bcor
Gt/Y ES cells can contribute to the B
and T lineages but they appear to be at a selective disadvantage, as
in OFCD patients, suggesting that Bcor is important for murine B
and T cell development.
Because BCOR is a known corepressor of BCL6, an important
regulator of germinal center formation in B-cell maturation, we
hypothesized that Bcor
Neo/Y and Bcor
Gt/Y cell contribution to
germinal center formation might be blocked or reduced in
chimeras. To test this, we looked for the presence of PNA, a
germinal center marker, in the CD19+ and Ly9.1+ cell population
in cells harvested from the spleens of both mutant chimeric lines.
Similar to the B and T cell analysis, we observed an 87%
reduction compared to control chimeras in Bcor
Neo/Y and Bcor
Gt/Y
contribution to CD19+ PNA+ cells suggesting a compromised
germinal center reaction (Figure 3B). To assess the ability of Bcor
Gt/Y
and Bcor
Neo/Y ES cells to contribute to adult erythrocyte lineages in
chimeras,a hemoglobinanalysiswasperformed,relyingongenotype
differences between host and ES-derived cells. Erythrocytes derived
from the 129 genetic background express ß-major and ß-minor
globin, while B6 erythrocytes express ß-single globin [31,32]. We
found that Bcor
Neo/Y and Bcor
Gt/Y ES cells can contribute to mature
red blood cells but the contribution is severely reduced compared to
the controls (Figure 3C).




The absence of OFCD males indicates an early and essential
role for Bcor in human development. The parent-of-origin effect
strongly suggests that Bcor plays an essential role in extraembryonic
tissue but Bcor may play additional roles earlier in development.
We used our two loss of function ES cell lines in in vitro
differentiation assays to test whether Bcor plays a role in ES cell
differentiation. ES cells cultured in suspension in the absence of
leukemia inhibitory factor (LIF) undergo primary differentiation
after 2 to 4 days to form simple embryoid bodies (EBs) [33,34].
These contain an outer endoderm layer surrounding an inner cell
mass. Around day 4, differentiation of columnar epithelium with a
basal lamina and formation of a central cavity occurs. Such cystic
EBs bear similarities to the egg cylinder-stage embryos [35–37]. By
6 days of differentiation, EBs are comparable to early organogen-
esis-stage embryos (E7.5) [38]. EB cells can be dispersed and
induced with appropriate growth conditions to undergo secondary
differentiation into particular cell lineages [34,39].
Both the severe skewing of X-inactivation seen in OFCD patients
and the limitedcontributionofBcormutantEScells to hematopoietic
lineages in our chimeric animals indicate that Bcor plays a role in
hematopoiesis. Primitive erythrocytes are the earliest hematopoietic
cell types to form in vivo [34,40]. Therefore, to determine whether
Bcor plays an early role in hematopoiesis, we first examined the
ability of dispersed embryoid bodies from our Bcor
Neo/Y and Bcor
Gt/Y
EScelllines todifferentiate into primitive erythrocyte(EryP)colonies
inthepresenceofappropriatefactors[41,42].WefoundEryPcolony
formation with CJ7 derived Bcor
Neo/Y and E14 derived Bcor
Gt/Y cell
lines is reduced relative to the matched parental ES cell lines (98%
and 97% respectively, Figure 4A).
We next used quantitative real-time polymerase chain reaction
(qRT-PCR) to examine expression of Flk1 (KDR), an early marker
Bcor in Early Development
PLoS ONE | www.plosone.org 5 July 2008 | Volume 3 | Issue 7 | e2814Figure 3. Analyses of Bcor
Neo/Y and Bcor
Gt/Y cell contribution to hematopoietic development in chimeric mice. (A) The Bcor
Neo/Y and Bcor
Gt/Y
129 strain derived ES cells can contribute to the B and T lineages. White blood cells from the spleens of Bcor
Neo/Y and Bcor
Gt/Y and appropriate controls
were stained with antibodies to the 129 strain specific surface antigen Ly9.1 and the T cell markers CD4 and CD8 and B cell marker CD19. Cells were
analyzed by flow cytometry and results are displayed as density plots with black boxes gating T or B cell populations of 129 origin. B6 and 129 strain wild
type mice control for Ly9.1 specificity. CJ7 and E14 129 mouse strain derived ES cells were used to generate control chimera 1 (Con. Ch. 1) and control
chimera 2 (Con. Ch. 2). Flow cytometry analyses were performed on chimeric control mice and on three mice for each mutant chimeric line, of which an
example scatter plot is displayed for each. (B) Compared to chimeric controls, Bcor
Neo/Y and Bcor
Gt/Y 129 strain derived ES cell contributionto B and T cells
is reduced. Graphs of scatter plot data show 129 strain contributions to each hematopoietic lineage. Black bars indicate the average contribution of
control chimeric mice 1 and 2 (Con, black +) and the combined average of three Bcor
Neo (Neo, red +) and three Bcor
Gt (Gt, blue +) mice. Contribution to
germinal center B cells is also reduced compared to controls as indicated by the final plot showing the PNA+ (peanut agglutinin; germinal center marker)
percentage of CD19+ 129 derived B cells. P values were #0.05 for all hematopoietic cell populations tested (CD4; 0.004, CD8; 0.034, CD19; 0.023 and PNA;
0.001). (C) Bcor
Neo/Y and Bcor
Gt/Y ES cells can contribute to adult erythrocytes in chimeric mice but contribution is reduced in comparison to controls.
Coomassie stained gel of hemolysates from erythrocytes of mice described above in panels A and B. Bcor
Neo and Bcor
Gt chimeric mice (Neo 1, 2 and 3 and
Gt 1, 2 and 3) primarily express B6 derived ß -single globin where as chimeric control mice 1 and 2 primarily express 129 derived ß -major and ß -minor
globin. The hemoglobin control lane (Hbb Con) was prepared from samples that contain ß -single, ß -major and ß -minor globin.
doi:10.1371/journal.pone.0002814.g003
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primitive and definitive hematopoiesis [43,44]. RNA samples were
collected from ES cells that were allowed to differentiate into
embryoid bodies for 0 to 5.5 days. We found that the induction of
Flk1 expression in Bcor
Neo/Y and Bcor
Gt/Y cell lines is delayed by one
day relative to the parental cell lines and in the time course of the
experiment Flk1 expression only reaches ,40% of the peak
expression seen in the parental cell lines (Figure 4B). Moving back
in developmental time, we examined expression of Brachyury (T),
a marker for the entire mesodermal lineage which in combination
Figure 4. In vitro differentiation of Bcor
Neo/Y and Bcor
Gt/Y ES cell lines. (A) Bcor
Neo/Y and Bcor
Gt/Y ES cell lines display a reduced ability to form
primitive erythrocyte colonies in comparison to control CJ7 and E14 parental lines. ES cell were differentiated into embryoid bodies for 4.5 days,
dispersed and replated in methylcellulose primitive erythrocyte colony forming assays. Error bars represent the standard error of the mean for each
ES cell line differentiated (CJ7 and Bcor
Neo/Y; n=3, E14 and Bcor
Gt/Y; n=5). (B–D) qRT-PCR analyses of gene expression were performed on embryoid
body differentiations (0–5.5 days) of Bcor
Neo/Y and Bcor
Gt/Y ES cell lines and respective parental control lines CJ7 and E14 (Bcor
+/Y). Differentiations
were performed in triplicate excluding the day 0 time point. Error bars represent the standard deviation within each time point of the samples
analyzed. (B) The expression of hematopoietic lineage marker, Flk1, is delayed approximately 1 day in Bcor
Neo/Y and Bcor
Gt/Y differentiating embryoid
bodies. (C) The expression of mesoderm and early hematopoietic lineage marker Brachyury is similarly delayed 1–2 days in Bcor
Neo/Y and Bcor
Gt/Y
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delay in expression of about 1–2 days but expression does
eventually peak at levels comparable to the parental ES cell lines
(Figure 4C). Finally, knowing that Bcor is expressed in ES cells, we
examined the expression of Oct3/4 (Pou5f1), a marker of ES cell
pluripotency [45,46], and found a one to two day delay in
repression of Oct3/4 (Figure 4D).
To confirm that these effects on ES cell differentiation are the
result of the Neo insertion in Bcor, we removed the Neo cassette from
the Bcor
Neo ES cell line. We generated three independent clonal
Bcor
Fl/Y ES cell lines via expression of Flpo recombinase [47] in
Bcor
Neo ES cells. We found that these three Bcor
Fl/Y ‘‘rescued’’ lines
restore the timing of expression of various ES cell and
differentiation markers to that of the parental wild type ES cells
(Figure 5) demonstrating that the effects on differentiation were
due to the interruption of Bcor by the Neo cassette. Included in the
analysis were a second ES cell marker, Nanog, the primitive
ectoderm marker, Fgf5, [48,49] and the extraembryonic ectoderm
marker, Bmp4 [35,50,51]. In the Bcor
Neo cells we observed a delay
in the downregulation of the ES cell markers Oct3/4 and Nanog,
whereas Fgf5 was still up regulated appropriately but its down
regulation was delayed by two days. Subsequently, activation of
Bmp4, Brachyury and Flk1 were all delayed by one to two days. For
the genes that are normally expressed earlier in differentiation, the
rescued lines restore both the timing and the level of gene
expression to that of the parental cell line. However with Brachyury
and Flk1, even though the normal timing of gene expression was
restored, inexplicably the level was increased beyond the parental
line. We also compared the proliferation rates and cell cycle profile
of the parental CJ7 ES cell line with the Bcor
Neo/Y and the three
rescued Bcor
Fl/Y ES cell lines and detected no significant
differences (data not shown).
Together these ES cell differentiation and expression studies
indicate that Bcor plays a role in the regulation of gene expression
very early in ES cell differentiation and in the mesodermal and
ectodermal lineages.
Discussion
In this study we have used a combination of mouse molecular
genetics and ES cell differentiation to identify roles of Bcor in early
development. These studies provide insights into the possible
causes of male embryonic lethality in OFCD, the hematopoietic
phenotype of female OFCD patients and the parent-of-origin
effect in mice. We have two major findings, as discussed below.
First, we found that in mice the mutant Bcor
Neo allele exhibits a
parent-of-origin effect, which together with the high level of Bcor
expression in extraembryonic tissue [22] strongly suggest an
essential requirement for Bcor in extraembryonic tissue. The X
chromosome has been implicated in causing several malformations
of the placenta [52] and our work suggests that Bcor is likely to be
one of the genes responsible.
There are two alternative but less likely explanations for the
parent-of-origin effect that we have considered. First, it is possible
that Bcor is required very early in development (beginning as early
as the 4 to 8 cell stage) when the whole embryo is subject paternal
X chromosome inactivation. Once the inner cell mass has formed
the cells of the embryo proper are subject to random X
inactivation. Paternal X-inactivation is maintained and becomes
more complete in the trophectoderm and primitive endoderm,
which go on to form to the extraembryonic tissue. However, given
the incomplete nature of the paternal imprinting during the 4 cell
to blastocyst stage it is most likely that sufficient levels of wild type
Bcor are transcribed to support development.
A second, albeit unlikely, alternative explanation for the parent-
of-origin effect observed in the mouse is that Bcor is imprinted such
that only the maternal allele is expressed in the embryo proper.
However, if such imprinting [53–55] occurred in humans, the
mother to daughter transmission seen in OFCD patients [56,57]
could not take place since the daughter would only express the
mutant Bcor allele and would be equivalent to the inviable
hemizygous males.
Our second major finding was that in ES cell differentiation
studies Bcor is required for formation of primitive erythrocytes and
proper expression of genes that regulate ES cell pluripotency and
genes that drive ectodermal and mesodermal development. These
defects together with the apparent limited contribution of Bcor
Neo/Y
and Bcor
Gt/Y cells to B and T cells and adult erythrocytes may
provide an explanation for the severe skewing of X-inactivation
seen in peripheral white blood cells of OFCD patients and indicate
a critical early role for Bcor in helping to establish hematopoietic
development. In data not included, we do not see significant
changes in expression of the few endoderm specific genes we
tested. Since the number of genes tested was not exhaustive, Bcor
may be affecting the expression of other genes important for
endoderm development that are yet unidentified.
One of the genes that we found to be misregulated in Bcor
Neo/Y
and Bcor
Gt/Y ES cell differentiation assays was Brachyury. Mice
heterozygous for the Brachyury T mutation exhibit a variable short-
tailed phenotype [58] while other mutations such as Brachyury T
137
have a kinked or bent tail [59]. Thus mis-expression of Brachyury is
a possible explanation for the kinked and shortened tails we
observed in Bcor
Neo/Y and Bcor
Gt/Y chimeras. The extraembryonic
ectoderm marker, Bmp4, was also misregulated in Bcor
Neo/Y ES cell
differentiation assays. Bmp4 knock out mice do not express
Brachyury and display impaired mesoderm differentiation, including
reduced extraembryonic mesoderm blood island formation and
disorganized posterior structures, further implicating Bcor in
mesoderm development [49].
Polycomb group proteins (PcG) have been shown to play a central
role in stem cell maintenance and lineage specification [60]. The
BCOR complex contains several PcG proteins, including RNF2, an
H2A ubiquitin ligase, and NSPC1, a BMI1 homolog [4]. RNF2 has
been shown to be present at over 1,200 targets in ES cells [61]. At
many genes, the PcG complex, PRC2, serves to recruit RNF2
containing complexes. However, about one quarter of ES cell RNF2
targets are not co-occupied with PRC2 components, suggesting
RNF2 can be recruited via other means. We hypothesize that
BCOR, via interaction with site specific transcription factors, can
recruit RNF2 and other BCOR complex components to regulate
expression of genes in ES cells and their differentiating progeny.
Recently, NSPC1 was identified as a protein that when over-
expressed can partially rescue the phenotypic properties of
undifferentiated mouse ES cells under differentiation-inducing
conditions [62]. Over-expression of NSPC1 may be sequestering
or diluting the activity of the Bcor complex thereby preventing full
transcriptional repression of target genes. This, together with our
data, suggests that inappropriate expression of BCOR complex
components affects ES cell differentiation.
Our studies suggest two possible causes of male embryonic
lethality in OFCD. First, inappropriate regulation of key develop-
mental genes in Bcor
2/Y embryos may cause lethality before
implantation. Second, male embryonic lethality may be due to
improper development of extraembryonic derived tissue, potentially
resulting in placental failure or incomplete chorioallantoic fusion.
Conditional inactivation of Bcor in a spatial and temporal manner
will be critical in future experiments in order to bypass the strict
requirement for Bcor function in early development.
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Animals
All experimental protocols involving mice described in this
publication have been approved by the University of Minnesota
Institutional Animal Care and Use Committee. The mice were not
kept in specific pathogen free (SPF) rodent housing, thus they were
exposed to multiple pathogens that are present at sub clinical levels
in conventional rodent housing. Due to continual pathogen
exposure, PNA+ CD19+ germinal center positive cell populations
were already present in our mice thus, we did not specifically
induce germinal center reactions through immunization.
Generation of Bcor mutant mice
Am o u s eBcor cDNA fragment containing sequences from within
exon 4 to within exon 7 was used to screen the RPCI-22 129S6/Sv
EvTac Bac library (Stratagene) [63], and positive BAC clones were
used to clone Bcor genomic sequence. The left and right homology
arms were cloned into the backbone vector pDZ157 [64]. The final
targeting construct is diagrammed in Figure 1A. The Bcor targeting
vector was linearized with PmeI and electroporated into CJ7 ES cells
(originally derived from the 129S1 strain). One homologous
recombinant was identified from 768 G418-resistant colonies by
Southern hybridization using a DNA probe from sequences
upstream of the targeting vector to screen genomic DNA digested
Figure 5. In vitro differentiation of Bcor
Fl/Y ‘‘rescued’’ ES cell lines. (A–C) Bcor
Fl/Y ‘‘rescued’’ ES cell lines were created through removal of the
Neo selection cassette via Flpo recombinase in vitro. Bcor
Fl/Y ES cells were clonally selected, screened for Neo removal and assessed for rescue of BCOR
protein expression by western blot (Figure 2C). qRT-PCR analyses of gene expression during embryoid body differentiation (0–6.5 days) of Bcor
+/Y
(CJ7, wild type parent line), Bcor
Neo/Y and three independent Bcor
Fl/Y ‘‘rescued’’ ES cell lines. Differentiations were performed in triplicate excluding the
day 0 time point. Bcor
Fl/Y results are the average of 3 independent Bcor
Fl/Y ‘‘rescued’’ lines each differentiated in triplicate. (A) The repression of
pluripotency markers, Oct3/4 and Nanog, is restored in Bcor
Fl/Y differentiating embryoid bodies in comparison to Bcor
Neo/Y. (B) Repression of the
primitive ectoderm marker, Fgf5, and expression of extraembryonic ectoderm marker, Bmp4, is restored in Bcor
Fl/Y differentiating embryoid bodies.
(C) Timing of expression of the early mesoderm and hematopoietic lineage markers, Brachyury and Flk1, is restored in Bcor
Fl/Y differentiating
embryoid bodies; however expression levels are restored to a higher magnitude with respect to Bcor
+/Y controls (CJ7, wild type parent line).
doi:10.1371/journal.pone.0002814.g005
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ends of the targeted region by Southern hybridization. Probes for
Southern hybridization were generated from a BAC clone
containing Bcor genomic sequence by PCR using primers
VBp525/VBp526 (59 probe, left arm) and VBp582/ VBp583 (39
probe, right arm). The targeted ES cell clone containing the Bcor
Neo
allele was injected into C57Bl/6 blastocysts to generate chimeras.
Chimeric males were bred with C57Bl/6 females to generate
heterozygotes carrying the Bcor
Neo allele. Bcor
Neo/+ females were bred
with male b-actin-Flpe transgenic mice to delete the frted sequence
and generate heterozygotes carrying the Bcor
Fl allele. Bcor
Fl/+ females
were bred with male b-actin-Cre transgenic mice to delete the floxed








The XE541 ES cell line was created by the BayGenomics
genetrap consortium through insertional genetrap mutagenesis of
the wild type E14 ES cell line (originally derived from the 129P2
strain). The genetrap mutation resides in the sixth intron of the
Bcor gene and results in a loss of function allele we named Bcor
Gt.
XE541 ES cells harboring the Bcor
Gt allele were injected into
C57Bl/6 blastocysts by the University of Minnesota Mouse





D3 alleles were detected by polymerase
chain reaction (PCR) from tail clip genomic DNA using primer set
VBp573 /VBp981. The described PCR generates an 1122 base
pair (bp) amplicon for the Bcor
Fl, a 993 bp amplicon for the Bcor
+
allele and a 332 bp amplicon for the Bcor
D3. The Bcor
Neo allele
was detected by separate PCR reaction using primer set,





In both western blot analyses performed, mouse eyes or ES cells
were incubated in lysis buffer (16phosphate buffered saline (PBS),
10% glycerol, 0.5% Nonidet-P40, 2 mM dithiothreitol (DTT),
0.2 mM phenylmethanesulphonylfluoride (PMSF) and 16 Com-
plete Protease Inhibitor (Roche)), sonicated, normalized by
Bradford Assay and resolved on a NuPAGE 3–8% Tris-Acetate
gel (Invitrogen). Proteins were transferred overnight at 4uCt oa
nitrocellulose membrane, blocked with non-fat dry milk and
incubated with polyclonal anti-BCOR [4] and monoclonal anti-B-
Actin antibodies (Abcam 8226).
Generation of ‘‘Rescued’’ Bcor
Fl/+ Embryonic Stem Cells
To remove the Neo selection cassette and restore BCOR
expression, Bcor
Neo/Y ES cells were transfected with a mouse codon-
optimized FLPo site specific recombinase as described by Raymond
and Soriano [47]. Five clonally selected rescued lines in which the Neo
cassette had been deleted were identified by PCR screening of gDNA
with primer sets VBp573 /VBp981 and VBp1023/VBp981.
Flow Cytometry and Hemoglobin Analyses
White blood cells were harvested into Hank’s buffered saline
solution (HBSS) at 4uC from the spleens of sacrificed Bcor
Neo, Bcor
Gt
and appropriate control mice. Cells were pelleted at 3006ga t4 uC
for this step and all subsequent centrifugation steps. Red blood
cells were lysed and white blood cells were then pelleted and
resuspended in a 1:3 dilution of clone 2.4G2 hybridoma (ATCC
HB-197) supernatant for 10 minutes at room temperature to block
Fc receptors. Cells were then counted and 2610
6 cells were
respuspended in 200 uL of FACs buffer (PBS, 1% FCS, and
0.02% azide, pH 7.2) in a 96 well round bottom plate for antibody
staining. Cells were stained with a 1:200 dilution of appropriate
primary antibody or lectin (Anti-Ly9.1-FITC (BD Pharmingen),
Anti-CD19-PE (eBioscience), Anti-CD4-PerCP (BD Pharmingen),
Anti-CD8-APC (eBioscience) and PNA-biotin (BD Pharmingen))
in FACs buffer for 20 minutes at room temperature and washed 1
time with 200 uL of FACs buffer. Cells incubated with PNA-biotin
were then incubated with streptavidin-APC for 20 minutes at
room temperature. All samples were then washed another 2 times
with FACs buffer, fixed in 1% paraformaldehyde and stored at
4uC until flow cytometry was performed on the following day. Cell
events were recorded on a flow cytometer (FACSCalibur; BD
Biosciences) and analyzed with FlowJo software (Tree Star Inc.).
Clarified hemolysates prepared from the erythrocytes of the same
mice were resolved by Triton-acid-urea gel electrophoresis and
visualized by Coomassie blue staining [32,65]
ES Cell Culture and Differentiation
ES cells were maintained in 37uC 5% CO2 incubator on
irradiated mouse embryonic fibroblasts (MEFs) in Knock Out
Dulbecco’s Modified Eagles Medium (KO-DMEM, Invitrogen)
supplemented with (15% ES cell certified fetal bovine serum (ES-
FBS, Hyclone), 0.1 mM non-essential amino acids (NEAA), 2 mM
L-glutamine, 0.1 mM 2-mercaptoethanol (BME), 100 U/ml
penicillin, 100 mg/ml streptomycin (Invitrogen) and 1000 U/mL
ESGRO (Chemicon)). Protocols for differentiation of ES cells were
essentially as described by Zhang et. al. [41,42] with minor
modifications. Briefly, ES cells were passaged one time onto 0.1%
gelatinized tissue culture plates to remove MEFs. After 2 days, cells
were trypsinized for 5 minutes to a single cell suspension, stopped
with fetal bovine serum, counted and plated at low density (5–
10610
4 cells/mL depending on the experiment) in embryoid body
(EB) differentiation media (Iscove’s Modified Dulbecco’s Medium
(IMDM) supplemented with 15% fetal bovine serum (Atlas
Biologicals), 50 ug/mL Ascorbic Acid (Sigma), 2 mM L-gluta-
mine, 4.5610
24 M monothioglycerol (MTG) in biological tripli-
cate for each sample on ultra low attachment tissue culture plates
(Corning)). EBs were maintained at 37uC 5% CO2 for duration of
indicated experiments. Primitive erythrocyte colony forming
assays utilized EBs, as described above, incubated until day 4.5.
EBs were then trypsinized to a single cells suspension, stopped with
FBS, counted and replated at 5610
3 cells/mL in triplicate in
primitive erythrocyte differentiation media containing (IMDM,
1% methylcellulose (Sigma), 10% plasma derived serum (Animal
Technologies Inc.), 12.5 ug/mL Ascorbic Acid (Sigma), 2 mM L-
glutamine (Invitrogen), 200 ug/mL transferrin (Roche),
4.5610
24 M MTG (Sigma), 2 U/mL Erythropoietin (Epogen,
Roche) and 5% protein free hybridoma media –II (Invitrogen). On
day 4 secondary differentiation plates were counted for the
presence of primitive erythrocyte colonies based on morphology
and color.
Gene Expression Analysis
Total RNA was extracted with TRIzol (Invitrogen), normalized
by spectroscopy and reverse transcribed using either M-MLV or
SuperScript III (Invitrogen) according to the manufacturer’s
protocol. Real-time quantitative PCR was performed using
Bcor in Early Development
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M63000P (Stratagene). Gene expression was determined using
the relative quantitation method [66] and Hprt expression was
used to normalize all sample template concentrations. Denaturing
curves were performed on all reactions to verify homogeneity of

















P values in Figure 3 were determined using a Student’s t-test,
using the natural log of the percent contribution values, assuming
unequal variances.
Supporting Information
Figure S1 Analysis of splicing pattern in BcorNeo/Y and BcorGt/Y
ES cells. (A) Clone 2B1 ES cells, containing the BcorNeo/Y allele,
aberrantly splice two portions of the Pgk-Neo coding sequence into
the Bcor transcript. S1–S4 shows the sequence surrounding the
splice junctions as determined by sequencing of reverse transcrip-
tion PCR products generated by primers A–D. Amplicon AB and
CD were sequenced to determine splice junctions S1–S3 and S4,
respectively. The predominant splice pattern found is indicated by
bolded black splice connector lines. VBp1114 (A) ATGCTTTCTG-
CAACCCCTCTGTAT, VBpNeoRev (B) TCGGCAGGAGCAA-
GGTGAGAT, VBpNeoFor (C) CCGGTTCTTTTTGTCAA-
GACCG, VBp1116 (D) TTGTATCCCAGGCGGTGTTTTG.
(B) Clone XE541 ES cells, containing the BcorGt/Y allele,
predominantly splice from exon 6 of Bcor into the splice acceptor
of the genetrap cassette. Reverse transcription PCR of XE541 ES
cell total RNA using primers F and G, generates the expected
amplicon of529 basepairs.Wildtypesplicing can alsobedetectedin
XE541 ES cells as shown by reverse transcription PCR using
primers E and H to generate the expected amplicon of 445 base
pairs. The predominant splice pattern found is indicated by bolded
black splice connector lines. VBp1616 (E) CGTGCAATGAT-
GCGCTTCTC, VBp1074 (F) AGATTCCAGTCAGCTCAGCC-
GAGA, VBp1071 (G) ATTCAGGCTGCGCAACTGTTGGG,
VBp1617 (H) CTTTGGAGATCCGTCTTCGCTT.
Found at: doi:10.1371/journal.pone.0002814.s001 (0.97 MB
DOC)
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